Proteins and Peptides

20 Jun 2007 ConjuChem Biotechnologies Reports PC-DAC(TM):Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
19 Jun 2007 Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
19 Jun 2007 Presentation of In Vivo HDL Kinetic Data at the European Atherosclerosis Society 76th Congress Demonstrates Activation of Reverse Cholesterol Transport by Pre-Beta HDL in Selectively Delipidated
16 Jun 2007 Novo Nordisk and Neose announce initiation of phase 1 clinical trial of long-acting factor VIIa
15 Jun 2007 Fabry Study Demonstrates Sustained, Long-Term Renal Stabilization After 54 Months
13 Jun 2007 IBPL Becomes Country's First Dedicated Biopharmaceutical Facility to Receive EU-GMP Certification
13 Jun 2007 Eurand Files NDA for Zentase(TM) for Exocrine Pancreatic Insufficiency
12 Jun 2007 Phase III clinical trial with 4-month long-acting formulation of triptorelin: Ipsen decides not to perform further administration
12 Jun 2007 Altus Pharmaceuticals Reacquires European Development and Commercialization Rights to ALTU-135
09 Jun 2007 Scios Announces Enrollment of First Patients in Ascend-HF
08 Jun 2007 Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
08 Jun 2007 Discovery Labs Initiates Phase 2 Clinical Trial in Children with Acute Respiratory Failure
08 Jun 2007 Human Genome sciences announces positive final results of Phase 2b trial of Albuferon(R)
08 Jun 2007 Lipid Sciences Announces Validation of Proprietary Peptide That Mimics Key Functions of Natural Human HDL
06 Jun 2007 Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated
05 Jun 2007 Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
05 Jun 2007 SciClone's SCV-07 Inhibits Melanoma Tumor Growth in Animal Model Study
05 Jun 2007 ONTAK(R) (denileukin diftitox) Achieves 49.1% Overall Response Rate in
04 Jun 2007 Xanthus announces Phase 1 results for P2045 - a targeted agent for nonsmall cell lung cancer
03 Jun 2007 Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
01 Jun 2007 Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
01 Jun 2007 Hemispherx Presents Potential Avian Influenza Treatment Breakthrough at Paris Conference
01 Jun 2007 Cytheris to start two phase I/IIa clinical trials of CYT107, its new recombinant Interleukin-7, in Hepatitis C and oncology
01 Jun 2007 Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex(TM) (ancrod)
01 Jun 2007 Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up